SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Agouron Pharmaceuticals (AGPH)
An SI Board Since March 1996
Posts SubjectMarks Bans Symbol
6136 24 0 AGPH
Emcee:  Bhag Karamchandani Type:  Unmoderated
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
5411 Margie, CNN is scheduled to air their piece on Agouron's rhinovirus proteasFergus-9/25/1998
5410 Merck slips on rival AIDS-drug data, profit taking Steve Fancy-9/25/1998
5409 Time for some consolidation. What a huge move from the recent lows. Consolidatbillkirn-9/25/1998
5408 Extremely thin volume today...looks like everyone's waiting to see whereSteve Fancy-9/25/1998
5407 Twice Daily Dosing of Viracept Demonstrates Activity at 48 Weeks Steve Fancy-9/25/1998
5406 At first blush, I'm not impressed at all with the Viramune results (no PI uIzzy-9/25/1998
5405 Yeah, I think you must be right about the short interest. I got the 83,392 figuJoe E.-9/25/1998
5404 Joe, I had noticed that, but I suspect the data is in error. Many of the NSteve Fancy-9/25/1998
5403 Something seems wrong with WSJ short interest numbers: Per: viwes.com AGPH AgJimieA-9/25/1998
5402 Actually, short interest rose from 7,304,820 to 8,339,202. Go figure... sam-9/25/1998
5401 Interesting Viramune results!! The Wall Street Journal reported today that shoJoe E.-9/25/1998
5400 Thanks Dennis. Here's some info on Viramune... Boehringer Ingelheim'sSteve Fancy-9/25/1998
5399 Steve, Twice a day dosing is good for revenues, as there is more drug sold (2 mod-9/25/1998
5398 CNN will be covering Agouron's presentation tomorrow, Compound Found to Remargie-9/25/1998
5397 Izzy, would it stand to reason that twice a day dosing would put pressure onSteve Fancy-9/25/1998
5396 38th Interscience Conference on Antimicrobial Agents and Chemotherapy CompoundSteve Fancy-9/25/1998
5395 AIDS Group Protests DuPont's Pricing Of New Drug Dow Jones Newswires WISteve Fancy-9/25/1998
5394 Lower Viracept dose works, Agouron (NASDAQ:AGPH) reports Steve Fancy-9/25/1998
5393 Nice meeting you here Steve, I am considering getting into this stock if it geMike-9/24/1998
5392 Impressive action this afternoon...the buyers came out. Apparently there isSteve Fancy-9/24/1998
5391 Looks like no more buyers at these levels. Some profit taking and likely renSteve Fancy-9/24/1998
5390 re: vertex I'm glad that Vertex finally applied for expanded access, becaumargie-9/23/1998
5389 I believe the S4/A or specifically the "/A" suggests an amendment Steve Fancy-9/23/1998
5388 You did not goof. The annual meeting was scheduled for October 28th. Is thereJimieA-9/23/1998
5387 I noticed in the recent s-4 that the annual meeting is on Nov. 16. Perhaps I mjake burns-9/23/1998
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):